Clinical TrialsSearch results
Number of results: 771
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- C arm Dynamic Perfusion Measurement Chronic ischemic diseases
- Chronic ischemic cerebrovascular diseases including carotid artery stenosis, carotid artery occlusio
- Yoshimura Shinichi
- 2019-03-30
Completed
- Search for new lung cancer biomarkers using 13C-labeled glucose
- Resectable primary lung cancer
- Yoshida Masaru
- 2020-07-30
Recruiting
- Verification of the cooling effect of a prototype cryotherapy device with deep body temperature control function around the knee joint in healthy individuals
- able-bodied person
- Yasuda Tadashi
- 2024-11-08
Completed
- fNIRS for CI mapping in patients with malformations
- bilateral severe sensorineural hearing loss
- Yamazaki Hiroshi
- 2020-06-25
Other
- Study to assess long-term safety in patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment
- CML, Ph+ ALL
- Yamauchi Kyosuke
- 2024-07-05
Completed
- Postoperative Analgesia of Intraoperative Dexmedetomidine Infusion during Laparoscopic Surgery : a randomized controlled study.
- Patients undergoing laparoscopic surgery under general anesthesia, without epidural anesthesia.
- Yamashita Hiroshi
- 2020-09-08
Not yet recruiting
- The efficacy of IDEC-C2B8 treatment for early-stage pediatric nephrotic syndrome
- Childhood-onset idiopathic nephrotic syndrome
- Yamamura Tomohiko
- 2024-08-07
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
Recruiting
- Phase III Study of KD-380
- Chronic inflammatory demyelinating polyradiculoneuritis and multifocal motor neuropathy
- Yamamoto Akihiko
- 2024-05-09
Other
- Multicenter phase II study of FOLFIRI and bevacizumab as second-line treatment in advanced or recurrent colorectal cancer.
- Colorectal Cancer
- Yakult Honsha Co.,Ltd.
- 2009-04-01